Annual report pursuant to Section 13 and 15(d)

Accounts Receivable

v3.19.3
Accounts Receivable
12 Months Ended
Dec. 31, 2018
Receivables [Abstract]  
Accounts Receivable

Note 4 – Accounts Receivable

 

Accounts receivable at December 31, 2018 and 2017 consisted of the following:

 

    December 31,  
    2018     2017  
Accounts receivable - Clinical Laboratory Operations   $ 622,009     $ 1,478,451  
Accounts receivable - Hospital Operations     31,607,644       8,593,747  
Total accounts receivable     32,229,653       10,072,198  
Less:                
Allowance for discounts - Clinical Laboratory Operations     (573,584 )     (1,177,054 )
Allowance for discounts - Hospital Operations     (25,066,799 )     (6,936,429 )
Allowance for bad debts     (2,777,521 )     (987,403 )
Accounts receivable, net   $ 3,811,749     $ 971,312  

 

For the years ended December 31, 2018 and 2017, bad debt expense was $9.4 million and $1.5 million, respectively.